Widad is collaborating with Rinani Dynamic Sdn Bhd to distribute the oral vaccine in Malaysia. It is being developed by US-based biotechnology company Vaxart.
KUALA LUMPUR: Widad Group Bhd’s foray into distributing an oral-based (tablet) Covid-19 vaccine developed by Vaxart, Inc moved a step forward after the phase one of the clinical trial achieved positive response.
Widad is collaborating with Rinani Dynamic Sdn Bhd to distribute the oral vaccine in Malaysia. It is being developed by US-based biotechnology company Vaxart.
Save 30% for ads-free and full access now!
